Handelsbanken Fonder’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Handelsbanken Fonder’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-525,178	Closed	-$7.66M	–	1658
2023 Q1	$7.66M	Sell	525,178 -891,468	-63%	-$12.6M	0.04%	358
2022 Q4	$10.3M	Buy	1,416,646 +41,045	+3%	+$290K	0.06%	301
2022 Q3	$9.52M	Hold	1,375,601	–	–	0.06%	283
2022 Q2	$9.62M	Buy	1,375,601 +60,000	+5%	+$468K	0.06%	299
2022 Q1	$10.9M	Buy	+1,315,601	New	+$11.9M	0.06%	293

Handelsbanken Fonder's AMYT Position: Q2 2023 in Review

Handelsbanken Fonder sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 525,178 shares — an estimated $7.66M sold.

Handelsbanken Fonder first reported a position in AMYT in Q1 2022 and held it in 5 quarters. The position peaked at $10.9M in Q1 2022. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

Handelsbanken Fonder reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Handelsbanken Fonder sold 525,178 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $7.66M.
Handelsbanken Fonder first reported a position in Amryt Pharma plc American Depositary Shares in Q1 2022 and held it in 5 quarters.
Handelsbanken Fonder's Amryt Pharma plc American Depositary Shares position peaked at $10.9M in Q1 2022.
0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Handelsbanken Fonder's 13F filing for Q2 2023, filed 2 Aug 2023.